ClinicalTrials.gg
Sign In

Urinary Bladder, Overactive clinical trials

The registry lists 858 studies for Urinary Bladder, Overactive across more than 10 countries. 127 are recruiting or about to start. 710 of them are mainly about Urinary Bladder, Overactive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

ClinicalTrials.gov finds 945 studies for Urinary Bladder, Overactive. How that becomes 858 here

This page counts the studies the registry files under Urinary Bladder, Overactive, and those it files under no condition that list Urinary Bladder, Overactivethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 945Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −29List Urinary Bladder, Overactive as a condition, but the registry did not file them under itMost often written as “Overactive Bladder Syndrome” (22), “Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency)” (1), and “Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence” (1). The registry filed them under other conditions only, most often Urinary Incontinence, Urge (6) and Lower Urinary Tract Symptoms (4).
  3. −58Match it another way52 name it in the title, 3 in a keyword, and 3 by a synonym or other text the search reads.
  4. 858The count on this page56 of them list Urinary Bladder, Overactive in their own words; the registry filed them under no condition.

Get an email when these change. Save the Urinary Bladder, Overactive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
520
Status unknown
100
Recruiting
74
Terminated
67
Not yet recruiting
44
Withdrawn
29

Phase

Phase 4
141
Phase 3
103
Phase 2
84
Phase 1
61
Early Phase 1
10

Where

United States
333
Turkey
67
Korea, Republic of
62
Canada
57
United Kingdom
57
France
53

Who runs them

Astellas Pharma Inc (42) · Pfizer (35) · Allergan (24) · National Taiwan University Hospital (13) · Pamukkale University (12) · Bayer (11) · Astellas Pharma Europe B.V. (9) · Far Eastern Memorial Hospital (9)

What is being tested here

Drugs under test in Urinary Bladder, Overactive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mirabegron61756
Solifenacin51754
Botulinum toxin type A31843
Tolterodine2428
Onabotulinum toxin A2510
Nitrofurantoin202
Oxybutynin1410
Lidocaine117
Tadalafil104
Nitrous Oxide102

Drug classes tested here Antimuscarinics 6 open · Beta-3 agonists 6 open · Estrogens 2 open · PDE5 inhibitors 1 open · NK1 receptor antagonists 3

Coming up

7phase 3 studies under way
48studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 74 Urinary Bladder, Overactive studies recruiting now, 45 (61%) set no upper age limit and 15 (20%) stop at 75 or younger. 6 (8%) take children under 18. 39 (53%) are for women only and 1 (1%) for men only; 8 (11%) take healthy volunteers.

Recruiting studies that take each age, of 74
AgeWomenMen
106 (8%)6 (8%)
1847 (64%)27 (36%)
3062 (84%)30 (41%)
4064 (86%)30 (41%)
5066 (89%)30 (41%)
6566 (89%)30 (41%)
7561 (82%)26 (35%)
8554 (73%)25 (34%)

Across all 858 studies, recruiting or not: 20% stop at 75 or younger and 14% at 65; 10% take children; 41% are for women only and 6% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Urinary Bladder, Overactive studies take

Of 54 phase 4 interventional studies under Urinary Bladder, Overactive, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 19 mo4–22 · 30 studies6 mo4–11 · 20 studies—
Phase 217 mo11–22 · 22 studies——
Phase 318 mo11–34 · 33 studies16 mo11–24 · 26 studies—
Phase 423 mo15–48 · 54 studies—29 mo18–51 · 42 studies
Interventional, no phase19 mo10–40 · 174 studies13 mo8–25 · 41 studies22 mo11–40 · 133 studies
Observational32 mo17–45 · 59 studies—35 mo17–50 · 46 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 858. Browse all 858 → or search them.